BioVisible FISH-kits are easy to use and validated tests developed for the detection of bacteria in different matrices. The advantages of the FISH-kits:
* Easy to use protocols
* Rapid results
* Strong signal
* Validated controls
* Convenient storage
Our FISH-kits are suitable for several matrices:
* Environmental
* Food/Feed
* Veterinary
* Human Diagnostics
Our R&D department can develop a test on request within 1-3 months. Please contact our R&D department for more information.
is active in Research and Development, analysis
services, production and
commercialisation of Molecular Microbial Diagnostics for the detection
and identification of micro organisms using a variety of molecular
approaches like, FISH, DGGE or TGGE, Q-PCR or real time PCR, DNA
micro array or other molecular techniques.
BioVisible offers a unique analysis service for the evaluation of the effects of probiotics and prebiotics on
Gut microflora using FISH (fluorescence in situ hybridization),
(T)DGGE ((Temperature)Denaturing Gradient Gel Electrophoresis)
and/or Real-time PCR.
Please contact us for more information
BioVisible sells microbial diagnostic test-kits under the name RiboTechnologies. Our products are aimed to meet the demands of modern medical, veterinary, food, agro and environmental applications. We also offer the opportunity to provide our customers with training and implementation programs. (T(D)GGE, FISH and Q-PCR)
BioVisible develops, tailor-made, advanced diagnostic tests based on DNA/RNA technology.
BioVisible technical expertise and constant development of its used techniques is ensured by involvement of the R&D division in national and international contract research projects. Larger projects often involve co-ordinated efforts with established research organisations. Of course BioVisible also operates this unique facility for smaller scale contract research projects that may range from a few hours to several months.
Our Unique Concept
Compared to traditional microbiological methods, molecular diagnostic technology is superior in performance both with respect to reliability and speed. However, due to the high costs of R&D this technology is relatively expensive. In order to decrease these costs BioVisible R&D is embedded in a broad technology implementation program supported by national institutes and governments. As a result, BioVisible is able to develop high-end tailor-made diagnostic tests at relatively low cost. Due to an extensive network of scientific and applied research institutions, exploration periods in R&D are minimised and developments are rapidly available for standardisation.
Ribosomal RNA probes for micro-organisms can be developed on request by our R&D unit.
Customised diagnostic developments from our R&D facility are subjected to rigorous validation procedures. The close contact between R&D and Manufacturing in our organisation ensures a short product-release time. Diagnostic Research by BioVisible is driven by the demand of key-customers in core markets. The most suitable technology is selected for each program, based on specifications such as volume, speed and resolution.
Please sent a mail to: m.rest@biovisible.com for further detailed information.
BioVisible starts a new analysis service using the Mitox™ DNA - Mitochondrial toxicity assay to measure simultaneously the nuclear DNA and mitochondrial RNA content of the cell. This assay can be used as a biomarker for toxicity and/or efficacy of antiviral treatment.
This analysis service is offered in collaboration with Primagen. Click Logo for preliminary website.
Did you know;
